Caspase-9 as a target for Pneumocystis pneumonia therapy.
Lasbury
Mark E
ME
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Wang
Shao-Hung
SH
Zhang
Chen
C
Liao
Chung-Ping
CP
Durant
Pamela J
PJ
Tschang
Dennis
D
Lee
Chao-Hung
CH
D000818:Animals; D017209:Apoptosis; D018893:Bronchoalveolar Lavage; D053455:Caspase 10 / Q000032:analysis; D053148:Caspase 3 / Q000032:analysis; D053181:Caspase 8 / Q000032:analysis; D053453:Caspase 9 / Q000096:biosynthesis*; D061945:Caspase Inhibitors; D002478:Cells, Cultured; D053938:DNA Fragmentation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D015151:Immunoblotting; D016867:Immunocompromised Host; D020287:In Situ Nick-End Labeling; D007958:Leukocyte Count; D008264:Macrophages / Q000276:immunology* / Q000473:pathology*; D011010:Pneumocystis; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000276:immunology; D051381:Rats; D017207:Rats, Sprague-Dawley
D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors; D053455:Caspase 10; D053148:Caspase 3; D053181:Caspase 8; D053453:Caspase 9